Analysis of efalizumab safety in patients with moderate to severe psoriasis and diabetes

被引：0
|
作者：
Chen, Yun [1 ]
Caro, Ivor [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2009年 / 60卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：AB164 / AB164
页数：1
相关论文
共 50 条
  • [1] Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis
    Leonardi, C
    Goffe, B
    Sobell, J
    Caro, I
    Wang, X
    Papp, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2004, 122 (03) : A58 - A58
  • [2] Safety events in moderate to severe psoriasis patients treated with efalizumab
    Ehrlich, Alison
    Caro, Ivor
    Werther, Winifred
    Chen, Yun
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (03) : AB181 - AB181
  • [3] Pharmacokinetic–Pharmacodynamic–Efficacy Analysis of Efalizumab in Patients with Moderate to Severe Psoriasis
    Chee M. Ng
    Amita Joshi
    Russell L. Dedrick
    Marvin R. Garovoy
    Robert J. Bauer
    Pharmaceutical Research, 2005, 22 : 1088 - 1100
  • [4] Safety and tolerability of extended efalizumab therapy in patients with chronic moderate to severe plaque psoriasis
    Gottlieb, A
    Hamilton, T
    Rafal, E
    Caro, I
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (03) : AB11 - AB11
  • [5] The safety of efalizumab in patients with moderate to severe plaque psoriasis: Summary of clinical trial experience
    Leonardi, C
    Goffe, B
    Sobell, J
    Caro, I
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P157 - P157
  • [6] Safety and efficacy of efalizumab therapy for elderly patients with moderate to severe chronic plaque psoriasis
    Gottlieb, A
    Lizzul, P
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P194 - P194
  • [7] Pharmacokinetic-pharmacodynamic-efficacy analysis of efalizumab in patients with moderate to severe psoriasis
    Ng, CM
    Joshi, A
    Dedrick, RL
    Garovoy, MR
    Bauer, RJ
    PHARMACEUTICAL RESEARCH, 2005, 22 (07) : 1088 - 1100
  • [8] Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis
    Papp, KA
    Miller, B
    Gordon, KB
    Caro, I
    Kwon, P
    Compton, PG
    Leonardi, CL
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (04) : S164 - S170
  • [9] Efalizumab for the treatment of moderate to severe plaque psoriasis
    Jordan, JK
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (09) : 1476 - 1482
  • [10] Efalizumab for patients with moderate to severe plaque psoriasis - A randomized controlled trial
    Gordon, KB
    Papp, KA
    Hamilton, TK
    Walicke, PA
    Dummer, W
    Li, N
    Bresnahan, BW
    Menter, A
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (23): : 3073 - 3080
12345